Cargando…
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance
Coronavirus disease-2019 (COVID-19), as a worldwide serious issue has been shown to lead to progression and poor outcomes in cancer patients. The underlying mechanisms for SARS-CoV-2 infection’s adverse effects on cancer patients have not been fully understood. We hypothesized that CD147 and Cycloph...
Autores principales: | Bakhtiyari, Maryam, Haji Aghasi, Ayda, Banihashemi, Sara, Abbassioun, Arian, Tavakol, Chanour, Zalpoor, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072013/ https://www.ncbi.nlm.nih.gov/pubmed/37016434 http://dx.doi.org/10.1186/s13027-023-00501-2 |
Ejemplares similares
-
Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
por: Han, Jang Mi, et al.
Publicado: (2022) -
Dealing with the family: CD147 interactions with cyclophilins
por: Yurchenko, Vyacheslav, et al.
Publicado: (2006) -
The Roles of CD147 and/or Cyclophilin A in Kidney Diseases
por: Qu, Xin, et al.
Publicado: (2014)